Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study

BACKGROUND: The benefits of intravenous immunoglobulin administration are controversial for critically ill COVID-19 patients. METHODS: We analyzed retrospectively the effects of immunoglobulin administration for critically ill COVID-19 patients. The primary outcome was 28-day mortality. Inverse prob...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, Xie, Jianfeng, Wu, Wenjuan, Li, Shusheng, Hu, Yu, Hu, Ming, Li, Jinxiu, Yang, Yi, Huang, Tingrong, Zheng, Kun, Wang, Yishan, Kang, Hanyujie, Huang, Yingzi, Jiang, Li, Zhang, Wei, Zhong, Ming, Sang, Ling, Zheng, Xia, Pan, Chun, Zheng, Ruiqiang, Li, Xuyan, Tong, Zhaohui, Qiu, Haibo, Weng, Li, Du, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828477/
https://www.ncbi.nlm.nih.gov/pubmed/35154067
http://dx.doi.org/10.3389/fimmu.2021.738532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828477/
https://www.ncbi.nlm.nih.gov/pubmed/35154067
http://dx.doi.org/10.3389/fimmu.2021.738532

Ejemplares similares